MIE Corporation Co., Ltd (XNGO:3442)
1,461.00
-38.00 (-2.54%)
At close: Aug 6, 2025
Oncternal Therapeutics Revenue
In the fiscal year ending March 31, 2025, MIE Corporation had annual revenue of 7.10B JPY with 4.21% growth. MIE Corporation had revenue of 1.80B in the quarter ending March 31, 2025, with 10.12% growth.
Revenue
7.10B
Revenue Growth
+4.21%
P/S Ratio
0.25
Revenue / Employee
54.60M
Employees
130
Market Cap
1.80B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Mar 31, 2025 | 7.10B | 287.00M | 4.21% |
Mar 31, 2024 | 6.81B | 232.00M | 3.53% |
Mar 31, 2023 | 6.58B | 882.00M | 15.48% |
Mar 31, 2022 | 5.70B | 859.00M | 17.76% |
Mar 31, 2021 | 4.84B | -738.00M | -13.24% |
Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Toyota Motor | 48.04T |
Mitsubishi UFJ Financial Group | 5,440.78B |
Sony Group | 12.96T |
Hitachi | 9,830.27B |
SoftBank Group | 7,243.75B |
Nintendo | 1,490.65B |
Sumitomo Mitsui Financial Group | 3,346.44B |
Fast Retailing | 3,354.04B |